• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FERROSAN MEDICAL DEVICES A/S SURGIFLO HEMOSTATIC MATRIX KIT WITH THORMBIN; SURGIFLO HEMOSTATIC MATRIX KIT WITH THORMBIN PRODUCT CODE 2993

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FERROSAN MEDICAL DEVICES A/S SURGIFLO HEMOSTATIC MATRIX KIT WITH THORMBIN; SURGIFLO HEMOSTATIC MATRIX KIT WITH THORMBIN PRODUCT CODE 2993 Back to Search Results
Lot Number 244984
Device Problem Insufficient Information (3190)
Patient Problems Cardiac Arrest (1762); Hematoma (1884)
Event Date 07/24/2015
Event Type  Injury  
Manufacturer Narrative
A number of clinical questions has been asked to clarify the event.(b)(4).
 
Event Description
Surgeon states that he used 3 units of surgiflo hemostatic matrix kit with thrombin on a pt who underwent an anterior cervical fusion with discectomy.The pt had no issues during the case.The pt later developed a massive hematoma in the neck and went in cardiac arrest.The pt revived and is doing well now per the surgeon.The staff at the hospital reported that the pt was a smoker but no other info about the pt was revealed.There is no additional info at this time.
 
Manufacturer Narrative
(b)(4).This report is our follow-up and final report.Summary of information provided: surgiflo hemostatic matrix kit with thrombin product code 2993 was used on a male patient who underwent an anterior cervical fusion with discectomy.The case took 3.5 hours and it is noted that the patient had a blood loss of 100ml.No complications in the initial post-op period were noted.The following day around lunch time the patient developed neck swelling that progressed to airway obstruction and respiratory arrest.The patient was re-operated and a hematoma was evacuated and drained for about 125ml.Following this the patient was doing fine and the patient was discharged home with no further complications.It is noted that the patient is a smoker.Evaluation and conclusion: batch file review has been performed and it is evaluated that there are no deviations with relation to this complaint.A number of clinical questions were asked as to obtain additional information.Multiple attempts were made to obtain the answers with only some of the questions being answered.The case has been evaluated by an external medical advisor who evaluates the following: the case is noted to have taken 3.5 hours which is somewhat longer than what would be anticipated for such a type of procedure.Three units of surgiflo hemostatic matrix kit with thrombin product code 2993 were used during the case which could indicate that there has been a substantial amount of bleeding during the case.During such a type of procedure there is a risk that the thyroid artery can be injured which then may evolve into post-operative bleeding and consequently development of hematoma.Based on the information received and external evaluation it is concluded that the adverse event is not caused as a result of the use of surgiflo hemostatic matrix kit with thrombin product code 2993.As per the enclosed instructions for use of surgiflo hemostatic matrix kit with thrombin product code 2993 there are two warnings: surgiflo is not intended as a substitute for meticulous surgical technique and the proper application of ligatures or other conventional procedures for hemostasis.Surgiflo should not be used in instances of pumping arterial hemorrhage.It should not be used where blood or other fluids have pooled or in case where the point of hemorrhage is submerged.The case is hereby considered closed.Single-use product.
 
Event Description
"surgeon states that he used 3 units of surgiflo hemostatic matrix kit with thrombin on a patient who underwent an anterior cervical fusion with discectomy.The patient had no issues during the case.The patient later developed a massive hematoma in the neck and went in cardiac arrest.The patient revived and is doing well now per the surgeon.The staff at the hospital reported that the patient was a smoker but no other information about the patient was revealed.There is no additional information at this time.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGIFLO HEMOSTATIC MATRIX KIT WITH THORMBIN
Type of Device
SURGIFLO HEMOSTATIC MATRIX KIT WITH THORMBIN PRODUCT CODE 2993
Manufacturer (Section D)
FERROSAN MEDICAL DEVICES A/S
sydmarken 5
soeborg, 2860
DA  2860
Manufacturer (Section G)
FERROSAN MEDICAL DEVICES A/S
sydmarken 5
soeborg, 2860
DA   2860
Manufacturer Contact
majbrit andersen
sydmarken 5
soeborg, 2860
DA   2860
MDR Report Key5015753
MDR Text Key23520563
Report Number3008478369-2015-00008
Device Sequence Number1
Product Code LMF
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,unknown
Reporter Occupation Other
Report Date 09/21/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/31/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2016
Device Lot Number244984
Other Device ID NumberN/K
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received07/29/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
-
-